Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET - PubMed (original) (raw)

Clinical Trial

Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET

Anthony K P Jones et al. Eur J Pain. 2004 Oct.

Abstract

Central neuropathic pain (CNP) is pain resulting from damage to the central nervous system. Up till now, it has not been possible to identify a common lesion or pharmacological deficit in these patients. This preliminary study in a group of patients with CNP with predominantly post-stroke pain, demonstrates that there is significantly less opioid receptor binding in a number of cortical and sub-cortical structures that are mostly, but not exclusively, within the medial pain system in patients compared to age-matched pain-free controls. The reductions in opioid receptor binding within the medial system were observed mainly in the dorsolateral (Brodman area 10) and anterior cingulate (Brodman area 24 with some extension into area 23) and insula cortices and the thalamus. There were also reductions in the lateral pain system within the inferior parietal cortex (Brodman area 40). These changes in binding could not be accounted for by the cerebral lesions shown by CT or MRI, which were outside the areas of reduced binding and the human pain system. To our knowledge this is the first systematic demonstration of a reduction in opioid receptor-binding capacity in neurones within the human nociceptive system in patients with CNP. This may be a key common factor resulting in undamped nociceptor activity within some of the structures that are predominantly within the medial nociceptive system. If confirmed, these findings may explain why certain patients with CNP require high doses of synthetic opiates to achieve optimum analgesia. The findings also raise the possibility of new pharmacological approaches to treatment.

PubMed Disclaimer

Cited by

[Positron emission tomography in pain research. From the structure to the activity of the opiate receptor system].
Sprenger T, Henriksen G, Valet M, Platzer S, Berthele A, Tölle TR. Sprenger T, et al. Schmerz. 2007 Nov;21(6):503-13. doi: 10.1007/s00482-007-0547-2. Schmerz. 2007. PMID: 17522897 Review. German.
Unravelling the mystery of pain, suffering, and relief with brain imaging.
Lee MC, Tracey I. Lee MC, et al. Curr Pain Headache Rep. 2010 Apr;14(2):124-31. doi: 10.1007/s11916-010-0103-0. Curr Pain Headache Rep. 2010. PMID: 20425201 Review.
Multifunctional Opioid-Derived Hybrids in Neuropathic Pain: Preclinical Evidence, Ideas and Challenges.
Starnowska-Sokół J, Przewłocka B. Starnowska-Sokół J, et al. Molecules. 2020 Nov 25;25(23):5520. doi: 10.3390/molecules25235520. Molecules. 2020. PMID: 33255641 Free PMC article. Review.
Development of a PET radioligand for α2δ-1 subunit of calcium channels for imaging neuropathic pain.
Zhou YP, Sun Y, Takahashi K, Belov V, Andrews N, Woolf CJ, Brugarolas P. Zhou YP, et al. Eur J Med Chem. 2022 Nov 15;242:114688. doi: 10.1016/j.ejmech.2022.114688. Epub 2022 Aug 18. Eur J Med Chem. 2022. PMID: 36031695 Free PMC article.
Reduced basal ganglia μ-opioid receptor availability in trigeminal neuropathic pain: a pilot study.
DosSantos MF, Martikainen IK, Nascimento TD, Love TM, Deboer MD, Maslowski EC, Monteiro AA, Vincent MB, Zubieta JK, DaSilva AF. DosSantos MF, et al. Mol Pain. 2012 Sep 24;8:74. doi: 10.1186/1744-8069-8-74. Mol Pain. 2012. PMID: 23006894 Free PMC article.

Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET - PubMed (original) (raw)